About
Bioactive Research through its New Zealand affiliate provides a wide range of bioassays and models to assist natural product health companies and drug developers. We work with partners to develop new products on a shared basis.
BIOASSAYS AND MODELS
A wide range of bioassays and models are available to assist natural product health companies. Staff members have worked in biotechnology developments for over 30 years.
We have experience with products and preparations, from a diversity of animal, botanical, marine, fungal, bacterial, algal and synthetic sources.
What we do
Bioactive Research, through its NZ affiliate can add value to your product development program and product development investment decisions. We work closely with you throughout the process.
Work interactively with you to properly understand your requirements and how we may assist you.
Exchange confidentiality or non-disclosure agreements with you.
IP from work on your contracted product remains yours. Our IP is only associated with our models and assays.
Develop a study design with you and discuss amending it as appropriate.
Prepare a formal proposal to you and appoint a project manager.
Schedule the research, order any materials needed (some special requirements may have several weeks lead time) and secure any required approvals (eg, ethical, biosecurity).
Conduct the research program while keeping you informed of progress regularly.
Prepare report on completion of the research and the outcome is discussed with you.
Follow up to discuss any matters arising from the report.
We work interactively with you to understand your needs and develop a plan of approach. Many of the products we have helped develop are now in the market or clinical trials.
Staff Profiles
Dr. Paul Davis
Director of Research
Dr. Paul F. Davis is the Director of Research, of Bioactive Research. Dr. Davis has continuously undertaken biological/biomedical research at research institutes, universities, and commercial organizations for over 43 years.
He has served as Senior Research Fellow and Director of the Bioactivity Investigation Group (BIG) at the University of Otago, New Zealand, Director of Research Unit at the Malaghan Institute of Medical Research, and Fulbright Research Fellow at the University of Texas at Austin. Dr. Davis has published 66 peer-reviewed research papers and he was named inventor on 13 patents.
Dr. Davis is involved with Research and Bioactivity Investigation
Extracellular matrix, Analysis and metabolism of collagens, elastin, glycosaminoglycans and proteoglycans in all organs and tissues. This includes both normal and abnormal activities and constituents.
Angiogenesis. A range of in vitro models including cell and tissue cultures are available. These are related to general angiogenesis, ocular angiogenesis, and haemangiomas. As well animal models are available.
Natural products and bioactivities. A wide range of biological models and assays to investigate applications of natural products and their derivatives in many health and disease applications. These include cell and tissue culture, biochemical, immunological and histological procedures. There are also in vivo models in regular use. These complement the in vitro ones.